
    
      The purpose of this study is to assess the performance of the Abbott Vascular MULTI-LINK
      FRONTIER Coronary Bifurcation Stent System (CBSS) with one and six months clinical outcomes,
      when used for bifurcation de novo or restenotic lesion treatment. The device allows for a
      stent to be implanted in the main branch and simultaneous preservation and access of the side
      branch for balloon dilatation or stenting when indicated.
    
  